Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1953 2
1962 2
1964 2
1965 2
1966 2
1968 1
1970 2
1971 3
1972 4
1973 4
1974 1
1975 4
1976 5
1977 5
1978 6
1979 8
1980 8
1981 11
1982 12
1983 5
1984 7
1985 13
1986 20
1987 25
1988 14
1989 28
1990 16
1991 25
1992 23
1993 50
1994 27
1995 38
1996 45
1997 43
1998 43
1999 42
2000 55
2001 66
2002 88
2003 114
2004 121
2005 154
2006 200
2007 209
2008 274
2009 337
2010 395
2011 499
2012 577
2013 632
2014 717
2015 765
2016 736
2017 831
2018 927
2019 1156
2020 1361
2021 1546
2022 162
Text availability
Article attribute
Article type
Publication date

Search Results

11,085 results
Results by year
Filters applied: . Clear all
Page 1
Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion.
Sun X, Wu B, Chiang HC, Deng H, Zhang X, Xiong W, Liu J, Rozeboom AM, Harris BT, Blommaert E, Gomez A, Garcia RE, Zhou Y, Mitra P, Prevost M, Zhang D, Banik D, Isaacs C, Berry D, Lai C, Chaldekas K, Latham PS, Brantner CA, Popratiloff A, Jin VX, Zhang N, Hu Y, Pujana MA, Curiel TJ, An Z, Li R. Sun X, et al. Among authors: wu b. Nature. 2021 Nov;599(7886):673-678. doi: 10.1038/s41586-021-04057-2. Epub 2021 Nov 3. Nature. 2021. PMID: 34732895
Retraction Note: The PI3K/mTOR Dual Inhibitor BEZ235 Nanoparticles Improve Radiosensitization of Hepatoma Cells Through Apoptosis and Regulation DNA Repair Pathway.
Tang X, Li A, Xie C, Zhang Y, Liu X, Xie Y, Wu B, Zhou S, Huang X, Ma Y, Cao W, Xu R, Shen J, Huo Z, Cai S, Liang Y, Ma D. Tang X, et al. Among authors: wu b. Nanoscale Res Lett. 2021 Dec 16;16(1):179. doi: 10.1186/s11671-021-03638-4. Nanoscale Res Lett. 2021. PMID: 34914025 Free PMC article. No abstract available.
Pharmacokinetics-based Chronotherapy.
Lu D, Wang Z, Wu B. Lu D, et al. Among authors: wu b. Curr Drug Metab. 2022 Jan 6. doi: 10.2174/1389200223666220106124218. Online ahead of print. Curr Drug Metab. 2022. PMID: 34994324
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial.
Zhu AX, Macarulla T, Javle MM, Kelley RK, Lubner SJ, Adeva J, Cleary JM, Catenacci DVT, Borad MJ, Bridgewater JA, Harris WP, Murphy AG, Oh DY, Whisenant JR, Lowery MA, Goyal L, Shroff RT, El-Khoueiry AB, Chamberlain CX, Aguado-Fraile E, Choe S, Wu B, Liu H, Gliser C, Pandya SS, Valle JW, Abou-Alfa GK. Zhu AX, et al. Among authors: wu b. JAMA Oncol. 2021 Nov 1;7(11):1669-1677. doi: 10.1001/jamaoncol.2021.3836. JAMA Oncol. 2021. PMID: 34554208 Free PMC article.
[Advances in microbial degradation of plastics].
Liu T, Xin Y, Liu X, Wu B, Xiang M. Liu T, et al. Among authors: wu b. Sheng Wu Gong Cheng Xue Bao. 2021 Aug 25;37(8):2688-2702. doi: 10.13345/j.cjb.200624. Sheng Wu Gong Cheng Xue Bao. 2021. PMID: 34472289 Free article. Review. Chinese.
Beta-carotene and its protective effect on gastric cancer.
Chen QH, Wu BK, Pan D, Sang LX, Chang B. Chen QH, et al. Among authors: wu bk. World J Clin Cases. 2021 Aug 16;9(23):6591-6607. doi: 10.12998/wjcc.v9.i23.6591. World J Clin Cases. 2021. PMID: 34447808 Free PMC article. Review.
Chest Mass in a Newborn Infant.
Wu BT, Stein-Wexler R, Li ST. Wu BT, et al. Pediatr Rev. 2022 Jan 1;43(1):e1-e5. doi: 10.1542/pir.2020-0058. Pediatr Rev. 2022. PMID: 34970691 No abstract available.
11,085 results
You have reached the last available page of results. Please see the User Guide for more information.